尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the detailed record of transactions filed by Reeve Emma, 董事. Director active across 1 company, notably PTC Therapeutics, INC.. Aggregated, 13 reports have been published. Split: 0 buy · 3 sells. Total volume traded: €611k. Activity tracked since 7 January 2022. The latest transaction was disclosed on 2 January 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13 条申报中的 13 条
Reeve Emma is Administrateur and has 13 filings in total. Across the 13 sampled filings, all in PTC Therapeutics, INC. (XNAS), the observed activity covers recent filings from 2022-01-11 to 2026-01-06, with 0 in purchases and 610876 in sales, and the modal transaction nature is Attribution.